Chronic lymphocytic leukemia (CLL) of B-cell type in relapse is a hematological malignancy characterized by the accumulation of functionally incompetent B-lymphocytes. This condition is clinically significant as it often leads to progressive disease, requiring careful monitoring and treatment adjustments. The ICD-10 Code C91.12 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage patient care and track disease prevalence.
ICD-10 Code C91.12 represents Chronic lymphocytic leukemia of B-cell type in relapse, indicating a return of the disease after a period of remission. This code is used when documenting the patient's clinical status, particularly when the disease has progressed or recurred, ensuring appropriate treatment plans and billing practices are followed.
Chronic lymphocytic leukemia of B-cell type in relapse occurs when previously treated CLL returns, often leading to increased lymphocyte counts and symptomatic manifestations. This condition necessitates prompt medical intervention due to its potential complications and impact on patient quality of life.
ICD-10 Code C91.12 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. This code is essential for both acute and chronic care settings, ensuring comprehensive documentation that supports clinical decision-making and billing accuracy.
In SOAP notes, ICD-10 Code C91.12 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of CLL in relapse. This code is crucial for maintaining continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Management of Chronic lymphocytic leukemia of B-cell type in relapse requires a multidisciplinary approach, often involving chemotherapy, targeted therapy, or immunotherapy. Hospitalization may be necessary for severe cases.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C91.12 is critical in medical billing, particularly in hospital, emergency room, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push, single or initial substance. |
| 36415 | Collection of venous blood by venipuncture. |
| 99214 | Established patient office visit, moderate complexity. |
Common Questions About Using ICD-10 Code C91.12 for Chronic lymphocytic leukemia of B-cell type in relapse
What are the common symptoms of Chronic lymphocytic leukemia of B-cell type in relapse?
Common symptoms include fatigue, weight loss, night sweats, and recurrent infections. Patients may also experience lymphadenopathy and splenomegaly.
How is Chronic lymphocytic leukemia of B-cell type in relapse treated?
Treatment may involve targeted therapies, chemotherapy, or immunotherapy, depending on the patient's overall health and disease progression.
When should ICD-10 Code C91.12 be used?
This code should be used when documenting a relapse of Chronic lymphocytic leukemia of B-cell type, particularly after a period of remission.
What is the importance of accurate coding for C91.12?
Accurate coding ensures proper reimbursement, facilitates appropriate treatment planning, and supports public health data collection.
Clinical Notes
SOAP notes
DAP notes
AI medical notes